These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

396 related items for PubMed ID: 17924864

  • 21. Patient and treatment perspectives: Revisiting the link between type 2 diabetes, weight gain, and cardiovascular risk.
    Peters AL.
    Cleve Clin J Med; 2009 Dec; 76 Suppl 5():S20-7. PubMed ID: 19952300
    [Abstract] [Full Text] [Related]

  • 22. Insulin detemir improves glycaemic control without weight gain in insulin-naïve patients with type 2 diabetes: subgroup analysis from the PREDICTIVE study.
    Dornhorst A, Lüddeke HJ, Sreenan S, Kozlovski P, Hansen JB, Looij BJ, Meneghini L, PREDICTIVE Study Group.
    Int J Clin Pract; 2008 Apr; 62(4):659-65. PubMed ID: 18324957
    [Abstract] [Full Text] [Related]

  • 23. Managing obesity and glycemic control in insulin-using patients: clinical relevance and practice recommendations.
    Gottesman I.
    Diabetes Res Clin Pract; 2004 Sep; 65 Suppl 1():S17-22. PubMed ID: 15315866
    [Abstract] [Full Text] [Related]

  • 24. Observational, open-label study of type 1 and type 2 diabetes patients switching from human insulin to insulin analogue basal-bolus regimens: insights from the PREDICTIVE study.
    Hermansen K, Dornhorst A, Sreenan S.
    Curr Med Res Opin; 2009 Nov; 25(11):2601-8. PubMed ID: 19739940
    [Abstract] [Full Text] [Related]

  • 25. [Insulin and weight gain: myth or reality?].
    Larger E, Rufat P, Dubois-Laforgue D, Ledoux S.
    Diabetes Metab; 2001 Nov; 27(5 Pt 3):S23-7. PubMed ID: 11910976
    [Abstract] [Full Text] [Related]

  • 26. Overcoming barriers to insulin replacement.
    Kuritzky L.
    J Fam Pract; 2009 Aug; 58(8 Suppl):S25-31. PubMed ID: 19679028
    [No Abstract] [Full Text] [Related]

  • 27. The role of new basal insulin analogues in the initiation and optimisation of insulin therapy in type 2 diabetes.
    Baxter MA.
    Acta Diabetol; 2008 Dec; 45(4):253-68. PubMed ID: 18766296
    [Abstract] [Full Text] [Related]

  • 28. Can amylin analogue lead to better diabetes control?
    Morrow T.
    Manag Care; 2003 Dec; 12(12):40-1. PubMed ID: 14723102
    [No Abstract] [Full Text] [Related]

  • 29. Safety and efficacy of glargine compared with NPH insulin for the treatment of Type 2 diabetes: a meta-analysis of randomized controlled trials.
    Bazzano LA, Lee LJ, Shi L, Reynolds K, Jackson JA, Fonseca V.
    Diabet Med; 2008 Aug; 25(8):924-32. PubMed ID: 18959605
    [Abstract] [Full Text] [Related]

  • 30. Assessing the controversies of insulin therapy in patients with type 2 diabetes mellitus.
    Kuritzky L, Nelson SE.
    J Fam Pract; 2005 Jun; 54(6):S3-6. PubMed ID: 16021782
    [No Abstract] [Full Text] [Related]

  • 31. Switching from an oral regimen to insulin in diabetes.
    Perry M.
    Community Nurse; 2000 May; 6(4):27-8. PubMed ID: 12778520
    [No Abstract] [Full Text] [Related]

  • 32. [Low carbohydrate diet slowed down the progression of renal insufficiency in type 2 diabetes. A case--difficult to draw conclusions].
    Vesti-Nielsen J, Westerlund P, Bygren P.
    Lakartidningen; 2000 May; 105(30-31):2094-7. PubMed ID: 18751447
    [No Abstract] [Full Text] [Related]

  • 33. The reality of glycaemic control in insulin treated diabetes: defining the clinical challenges.
    Davies M.
    Int J Obes Relat Metab Disord; 2004 Sep; 28 Suppl 2():S14-22. PubMed ID: 15306833
    [Abstract] [Full Text] [Related]

  • 34. Treatment of type 2 diabetes with combined therapy: what are the pros and cons?
    Massi-Benedetti M, Orsini-Federici M.
    Diabetes Care; 2008 Feb; 31 Suppl 2():S131-5. PubMed ID: 18227473
    [Abstract] [Full Text] [Related]

  • 35. [How to minimize weight gain associated with insulin treatment].
    Philippe J.
    Rev Med Suisse; 2010 Jun 09; 6(252):1199-200, 1202-4. PubMed ID: 20614755
    [Abstract] [Full Text] [Related]

  • 36. Oral combination therapy: repaglinide plus metformin for treatment of type 2 diabetes.
    Raskin P.
    Diabetes Obes Metab; 2008 Dec 09; 10(12):1167-77. PubMed ID: 18494804
    [Abstract] [Full Text] [Related]

  • 37. Switching patients from insulin glargine-based basal-bolus regimens to a once daily insulin detemir-based basal-bolus regimen: results from a subgroup of the PREDICTIVE study.
    Yenigun M, Honka M.
    Int J Clin Pract; 2009 Mar 09; 63(3):425-32. PubMed ID: 19222627
    [Abstract] [Full Text] [Related]

  • 38. Suggested insulin regimens for patients with type 1 diabetes mellitus who wish to fast during the month of Ramadan.
    Kobeissy A, Zantout MS, Azar ST.
    Clin Ther; 2008 Aug 09; 30(8):1408-15. PubMed ID: 18803984
    [Abstract] [Full Text] [Related]

  • 39. [Hypertension and insulin treatment in type 2 diabetes].
    Ben Salem Hachmi L, Bouguerra R, Maatki O, Smadhi H, Turki Z, Hraoui S, Ben Slama C.
    Arch Mal Coeur Vaiss; 2007 Aug 09; 100(8):664-7. PubMed ID: 17928772
    [Abstract] [Full Text] [Related]

  • 40. Biphasic insulin aspart 30 three times daily is more effective than a twice-daily regimen, without increasing hypoglycemia, in Chinese subjects with type 2 diabetes inadequately controlled on oral antidiabetes drugs.
    Yang W, Ji Q, Zhu D, Yang J, Chen L, Liu Z, Yu D, Yan L.
    Diabetes Care; 2008 May 09; 31(5):852-6. PubMed ID: 18268073
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 20.